https://www.selleckchem.com/products/nst-628.html
Cancer sequencing efforts have revealed that cancer is the most complex and heterogeneous disease that affects humans. However, radiation therapy (RT), one of the most common cancer treatments, is prescribed on the basis of an empirical one-size-fits-all approach. We propose that the field of radiation oncology is operating under an outdated null hypothesis that all patients are biologically similar and should uniformly respond to the same dose of radiation. We have previously developed the genomic-adjusted radiation dose, a method that
Like
Comment
Share
